Chongqing Pharscin Pharmaceutical Co., Ltd. (SHE:002907)

SHE:002907 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Cash & Equivalents	297.08	456.55	437.56	503.53	429.97	481.41
Short-Term Investments	-	30.35	50	-	-	-
Trading Asset Securities	250.5	120.61	-	-	80.61	50.07
Cash & Short-Term Investments	547.58	607.51	487.56	503.53	510.58	531.47
Cash Growth	23.68%	24.60%	-3.17%	-1.38%	-3.93%	10.71%
Accounts Receivable	323.17	272.7	245.46	315.03	238.5	225.99
Other Receivables	4.59	3.06	4.24	9.6	4.33	4.29
Receivables	327.76	275.76	249.71	324.63	242.83	230.27
Inventory	127.82	140.13	151.68	114.76	127.44	118.57
Prepaid Expenses	-	-	-	-	-	0.04
Other Current Assets	88.2	7.95	5.69	14.03	13.25	8.66
Total Current Assets	1,091	1,031	894.64	956.95	894.1	889.01
Property, Plant & Equipment	522.48	537.74	593.41	621.94	654.21	673.61
Long-Term Investments	92.42	93.65	98.39	84.48	57.05	36.92
Other Intangible Assets	121.09	125.89	107.14	75.26	76.79	53.48
Long-Term Deferred Tax Assets	14.92	17.26	15.69	18.66	16.96	18.59
Long-Term Deferred Charges	38.88	36.97	60.96	44.01	24.89	22.41
Other Long-Term Assets	72.41	74.7	81.23	65.37	47.48	27.39
Total Assets	1,954	1,918	1,851	1,867	1,771	1,721
Accounts Payable	68.47	64.36	55.23	48.04	76.1	92.05
Accrued Expenses	8.01	32.3	29.44	40.29	26.94	21.68
Short-Term Debt	-	-	-	-	-	12.01
Current Portion of Leases	0.09	0.09	0.14	0.11	0.13	-
Current Income Taxes Payable	18.76	4.62	0.76	1.97	0.18	7.8
Current Unearned Revenue	5.5	9.74	5.69	6.73	4.35	30.9
Other Current Liabilities	109.12	100.93	97.41	114.18	99.27	91.36
Total Current Liabilities	209.94	212.03	188.68	211.32	206.97	255.8
Long-Term Debt	-	-	-	-	250.92	235.35
Long-Term Leases	0.16	0.04	0.14	0.06	0.08	-
Long-Term Unearned Revenue	40.91	42.99	43.03	43.59	46.33	46.98
Long-Term Deferred Tax Liabilities	2.06	2.48	1.68	1.3	1.27	1.45
Total Liabilities	253.07	257.55	233.53	256.28	505.56	539.59
Common Stock	417.6	417.6	417.6	417.6	401.69	401.7
Additional Paid-In Capital	459.48	459.33	458.73	454.72	129.12	130.79
Retained Earnings	823.25	782.89	741.66	738.19	659.79	579.26
Treasury Stock	-	-	-	-	-6.55	-11.9
Comprehensive Income & Other	0.17	0.18	-0.07	-0.11	81.87	81.97
Total Common Equity	1,700	1,660	1,618	1,610	1,266	1,182
Shareholders' Equity	1,700	1,660	1,618	1,610	1,266	1,182
Total Liabilities & Equity	1,954	1,918	1,851	1,867	1,771	1,721
Total Debt	0.24	0.13	0.28	0.17	251.12	247.36
Net Cash (Debt)	547.34	607.39	487.28	503.36	259.45	284.11
Net Cash Growth	23.67%	24.65%	-3.19%	94.01%	-8.68%	9.38%
Net Cash Per Share	1.31	-	1.17	1.25	0.65	0.71
Filing Date Shares Outstanding	417.6	-	417.6	417.6	401.71	401.7
Total Common Shares Outstanding	417.6	-	417.6	417.6	401.69	401.7
Working Capital	881.41	819.31	705.96	745.63	687.13	633.21
Book Value Per Share	4.07	-	3.87	3.86	3.15	2.94
Tangible Book Value	1,579	1,534	1,511	1,535	1,189	1,128
Tangible Book Value Per Share	3.78	-	3.62	3.68	2.96	2.81
Buildings	-	310.3	310.25	297.72	292.53	290.78
Machinery	-	598.97	582.48	566.85	536.22	427
Construction In Progress	-	10.19	25.78	17.52	23.55	95.9

Updated Oct 28, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.